Inogen's board has approved a $15 million increase to the company's share repurchase authorization, contingent on closing the Rotech deal. The expansion brings total buyback capacity to $45 million, with an expiration set for June 30, 2028. The company isn't obligated to repurchase any specific number of shares.

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.